Cocrystal Pharma Inc 's

• COCP's Stock Performance relative to its Competitors

Vir Biotechnology Inc Share Performance +123.80% One Year

Vir Biotechnology Inc Profile Vir Biotechnology Inc is a clinical-stage immunology company that focuses on developing and commercializing innovative treatments for infectious diseases. Their business model revolves around the discovery and development of antibody therapies and other immunological approaches to combat a wide range of viral pathogens. They collaborate with leading research institutions and pharmaceutical companies to accelerate the development and commercialization of their products. More about Vir Biotechnology Inc 's Market Share

Eli Lilly And Company Share Performance -5.21% Over The Past 5 Days

Eli Lilly And Company Profile Eli Lilly and Company operates as a global pharmaceutical firm that focuses on developing innovative medicines in areas such as diabetes, oncology, and neurodegeneration. Their business model emphasizes research and development, strategic partnerships, and a strong commitment to improving patient outcomes through advanced therapeutics. More about Eli Lilly And Company's Market Share

Kyntra Bio Inc Share Performance -14.74% This Year

Kyntra Bio Inc Profile The company conducts preclinical development and clinical trials for its product candidates. More about Kyntra Bio Inc 's Market Share

Johnson and Johnson Share Performance -1.58% Over The Past 5 Days

Johnson and Johnson Profile Johnson & Johnson operates as a multinational healthcare company with a diversified business model that spans pharmaceuticals, medical devices, and consumer health products. By focusing on innovation and strategic acquisitions, the company aims to improve global health and well-being. More about Johnson and Johnson's Market Share

Iterum Therapeutics Plc Share Performance -92.06% One Year

Iterum Therapeutics Plc Profile Iterum Therapeutics Plc is a pharmaceutical company that focuses on the research, development, and commercialization of innovative anti-infectives for the treatment of serious and life-threatening infections. They aim to address unmet medical needs in this space by advancing their product candidates through clinical trials and ultimately bringing them to market. More about Iterum Therapeutics Plc's Market Share

Sources: Cocrystal Pharma Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Monday, August 31, 2026 11:52 AM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Cocrystal Pharma Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.